UBS analyst Matthew Weston maintained a Buy rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF338.00. The ...

Mother took Evrysdi for SMA before birth; baby later received Zolgensma. Dr. Richard Finkel at St. Jude led study showing no ...

Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation ...

PTC Therapeutics (NASDAQ:PTCT – Get Free Report) is projected to post its quarterly earnings results after the market closes on Thursday, February 27th. Analysts expect PTC Therapeutics to post ...